Venture Update: Monogram Orthopedics Closes $22 Million Reg A+ CF Round

Successful raises, in general, are a good sign.

For a pre-revenue company to close a successful first-raise is often times considered a sign of market validation.

Subsequent successful raises are generally good as well.

Monogram’s recent Reg A+ CF round closed at over $22 Million. This is uncanny.

Why do we like Monogram Orthopedics?

  • Traction: This venture broke the “pre-revenue” mold last year
  • Funding: A $22 Million CF round is beyond impressive
  • Disruptor: The current surgical robotic leader has 87% of market share; that’s a long way to fall
  • Total Addressable Market: Just knee replacements alone are a near $20 Billion market

Monogram Orthopedics also intends to go public; which is a good sign for future growth prospects.

Keep an eye on this one.

Blessings.

top